HMGA2 is aberrantly regulated in a broad range of human cancers, including lung [34], breast [35], and ovarian cancers [36] and increased expression of HMGA2 correlates with a higher risk of cancer progression. This evidence concerns the gene HMGA2 and ovarian cancer.